AUM Biosciences joins JLABS community:

We are excited to share some remarkable news that marks a significant milestone in our journey towards advancing precision oncology therapeutics. AUM Biosciences is now a proud member of the JLABS family!

This partnership as a Johnson & Johnson Innovation - JLABS company is a testament to is an important step in helping us deliver on our commitment to developing innovative, targeted therapies that address the unmet needs in oncology. Joining the JLABS ecosystem will provide us with unparalleled access to world-class resources, expertise, and an extensive network that will accelerate our research and development efforts.

What This Means for AUM Biosciences:

1. Enhanced Innovation and Collaboration: As part of JLABS, we will collaborate with some of the brightest minds in the industry. This vibrant community of innovative startups fosters a culture of creativity and knowledge-sharing, essential for groundbreaking discoveries.
2. Strategic Support and Mentorship: Through JLABS, we will gain access to invaluable mentorship from industry veterans and experts at Johnson & Johnson Innovation. Their guidance and insights will be instrumental in refining our strategies and navigating the complexities of the biotech landscape.
3. Increased Visibility and Opportunities: As a JLABS company, AUM Biosciences will benefit from increased visibility within the global biotech community. This will open up new opportunities for partnerships, collaborations, and funding, propelling us towards our goals more swiftly.

We are excited about development of our portfolio of precision oncology therapeutics including Tinodasertib in Colorectal Cancer, AUM302 in transforming the breast cancer paradigm. We are incredibly grateful to our dedicated team, partners, and supporters who have been instrumental in bringing us to this exciting juncture.

As we embark on this new chapter with JLABS, we remain steadfast in our dedication to transforming the landscape of precision oncology.?We are confident that this partnership will enable us to make even greater strides in our quest to develop life-changing therapies for cancer patients worldwide.

Thank you for your continued support. Stay tuned for more updates as we continue to push the boundaries of science and innovation. Together, we can create a brighter future for those affected by cancer.